Table 1.
Gene Ontology enrichment analysis based on the 80 prognostic differentially expressed genes.
| ID | Category | Description | GeneRatio | P value | P.adjust | Count | Gene ID |
|---|---|---|---|---|---|---|---|
| GO: 0006959 | BP | Humoral immune response | 10/48 | 2.5E-09 | 1.76E-06 | 10 | IGLV2-11/IGHV2-5/CFI, etc. |
| GO: 0006898 | BP | Receptor-mediated endocytosis | 10/48 | 5.75E-09 | 2.02E-06 | 10 | IGLV2-11/IGHV2-5IGHA1, etc. |
| GO: 0016485 | BP | Protein processing | 9/48 | 7.53E-08 | 1.77E-05 | 9 | IGLV2-11/IGHV2-5/CMA1, etc. |
| GO: 0006958 | BP | Complement activation, classical pathway | 6/48 | 1.5E-07 | 2.65E-05 | 6 | IGLV2-11/IGHV2-5/CFI, etc. |
| GO: 0038095 | BP | Fc-epsilon receptor signaling pathway | 7/48 | 3.12E-07 | 3.12E-05 | 7 | IGLV2-11/IGHV2-5/IGHE, etc. |
| GO: 0031012 | CC | Extracellular matrix | 8/50 | 3.12E-05 | 0.001715 | 8 | COL6A5/COL6A6/MMP25, etc. |
| GO: 0062023 | CC | Collagen-containing extracellular matrix | 7/50 | 8.71E-05 | 0.002396 | 7 | COL6A5/COL6A6/TPSAB1, etc. |
| GO: 0072562 | CC | Blood microparticle | 3/50 | 0.007144 | 0.090592 | 3 | IGHV3-13/IGHA2/IGHA1 |
| GO: 0005782 | CC | Peroxisomal matrix | 2/50 | 0.008236 | 0.090592 | 2 | HAO2/DDO |
| GO: 0031907 | CC | Microbody lumen | 2/50 | 0.008236 | 0.090592 | 2 | HAO2/DDO |
| GO: 0003823 | MF | Antigen binding | 9/44 | 1.41E-10 | 1.34E-08 | 9 | IGLV2-11/IGLV3-16/IGHE, etc. |
| GO: 0004252 | MF | Serine-type endopeptidase activity | 4/44 | 0.000384 | 0.018241 | 4 | TPSAB1/CFI/CTSG, etc. |
| GO: 0008236 | MF | Serine-type peptidase activity | 4/44 | 0.000735 | 0.019613 | 4 | TPSAB1/CFI/CTSG, etc. |
| GO: 0017171 | MF | Serine hydrolase activity | 4/44 | 0.000826 | 0.019613 | 4 | TPSAB1/CFI/CTSG, etc. |
| GO: 0004175 | MF | Endopeptidase activity | 5/44 | 0.001412 | 0.025427 | 5 | ECEL1/TPSAB1/CFI, etc. |
GO – Gene Ontology.